Clinical trial
Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
NCT00319306 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
- Lead sponsor
- AstraZeneca
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2005
- Completion date
- December 31, 2006
- Enrollment
- 550
- Sites
- 59
Conditions
As the registry lists them; a condition with its own page is linked.